updated 6/15/2011 2:46:18 PM ET 2011-06-15T18:46:18

BRANFORD, Conn., June 15, 2011 (GLOBE NEWSWIRE) -- Medline Industries, Inc. and CAS Medical Systems, Inc. (Nasdaq:CASM) today announced a distribution agreement for a co-branded version of CASMED's Model 740 portable vital signs monitor. The monitor will feature CASMED's proprietary Motion Artifact Extraction (MAXNIBP®) technology, the most advanced technology for non-invasive blood pressure measurement.

"Changes in the hospital environment such as nursing shortages and the need to monitor all areas of the hospital are driving a need for more flexible solutions," said Maroun Abouzeid, President of Medline's Preferred HealthCare Products Division. "CASMED brings a wealth of knowledge and innovation that will allow us to expand our diagnostic product offering within the acute care setting."

All of these co-branded monitors feature CASMED's NIBP technology which has a proven reputation for fast, accurate blood pressure determinations under the most challenging conditions for patients ranging from neonatal to adult. Oximetry options include Masimo SET® and Nellcor® OxiMax®, making the monitor a versatile, mobile unit for diverse types of clinical applications, especially in conditions of low perfusion and motion.

 "We are very excited about this new venture between CASMED and Medline," said Matthew J. Herwig, VP of Global Sales and Marketing for CASMED. "We believe that Medline's expertise in distribution, specifically to hospitals, surgery centers and physician offices, will expand our market share and open new opportunities for our best-in-class bedside monitor and our patented blood pressure technology."

About CASMED® – Monitoring What's Vital

CAS Medical Systems, Inc. is a leading developer and manufacturer of medical devices for non-invasive patient monitoring. The company's product lines include the high-acuity monitoring capabilities of the FORE-SIGHT Absolute Tissue Oximeter, the bedside patient monitoring line of vital signs monitoring products, proprietary non-invasive blood pressure measurement technology, and supplies and service including products for neonatal intensive care. CASMED products are designed to meet the needs of a full spectrum of patient populations worldwide, ranging from adults to pediatrics and neonates.

For further information regarding CAS Medical Systems, Inc., visit www.casmed.com.

The CAS Medical Systems, Inc. logo is available at http://www.globenewswire.com/newsroom/prs/?pkgid=4675

About Medline Industries, Inc. 

Medline, the nation's largest privately held manufacturer and distributor of healthcare products, manufactures and distributes more than 125,000 products to hospitals, extended care facilities, surgery centers, physician offices and home care dealers. Headquartered in Mundelein, Ill., Medline has more than 1,100 dedicated sales representatives nationwide to support its broad product line and cost management services.

Over the past five years, Medline has been the fastest-growing distributor of medical and surgical supplies in the U.S., serving as the primary distributor to over 450 major hospitals and healthcare systems. As a leading distributor, Medline offers a comprehensive array of consulting and management services encompassing the supply chain and logistics, utilization and standardization, business tools and enhanced reporting capabilities and on-staff clinicians.

Medline has a growing network of 50 manufacturing and distribution centers worldwide, as well as an expanding, dedicated transportation fleet with over 200 vehicles in a variety of sizes to fit customers' specific delivery needs. The fleet is equipped with the latest navigation devices for enhanced order tracking and communication.

For more information on Medline, visit www.medline.com.

Statements included in this press release, which are not historical in nature, are forward-looking statements made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Statements relating to the future financial performance of the Company are subject to many factors including, but not limited to, customer acceptance of the Company's products in the market, the introduction of competitive products and product development, the impact of any product liability or other adverse litigation, working capital and availability of capital, commercialization and technological difficulties, the impact of actions and events involving key customers, vendors, and competitors and other risks detailed in the Company's Form 10-K for the year ended December 31, 2010 and other subsequent Securities and Exchange Commission filings.

Such statements are based upon the current beliefs and expectations of the Company's management and are subject to significant risks and uncertainties. Actual results may differ from those set forth in the forward-looking statements. When used in this press release, the terms "anticipate," "believe," "estimate," "expect," "may," "objective", "plan," "possible," "potential", "will" and similar expressions identify forward-looking statements. The forward-looking statements contained in this press release are made as of the date hereof, and we do not undertake any obligation to update any forward-looking statements, whether as a result of future events, new information or otherwise.

CONTACT: CAS Medical Systems, Inc.
         Susan Carron
         Director of Corporate Communications
         (203) 488-6056
         Medline Industries, Inc.
         Media Contacts:
         Jerreau Beaudoin (847) 643-3011
         John Marks (847) 643-3309

© Copyright 2012, GlobeNewswire, Inc. All Rights Reserved


Discussion comments


Most active discussions

  1. votes comments
  2. votes comments
  3. votes comments
  4. votes comments

Data: Latest rates in the US

Home equity rates View rates in your area
Home equity type Today +/- Chart
$30K HELOC FICO 3.79%
$30K home equity loan FICO 4.99%
$75K home equity loan FICO 4.69%
Credit card rates View more rates
Card type Today +/- Last Week
Low Interest Cards 13.83%
Cash Back Cards 17.80%
Rewards Cards 17.18%
Source: Bankrate.com